Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Phase I
Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of…
Clinical
Deciphera’s investigational GIST drug ripretinib granted priority review by FDA
Clinical
Eisai complies with FDA request to pull weight-loss drug Belviq from…
Clinical
FDA grants priority review to Bristol-Myers Squibb’s filing for liso-cel in…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Acerus Announces Private Placement and Refinancing Transactions
Commercial
Following Clinical Hold and Trial Setback, Ipsen Takes $728 Million Hit…
Commercial
Indivior Full Year 2019 Results Now Available; Leadership Presentation Today
Deals
Sensorion Announces the Full Conversion of Sofinnova Partners Convertible Bonds Into…
Home
Clinical
Phase IV
Phase IV
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase IV
First Patient Enrolled in Mallinckrodt Phase 4 Trial of Acthar Gel (Repository Corticotropin Injection) for Severe Keratitis
Firstwordpharma News
-
December 16, 2019
- Advertisement -
MOST POPULAR
CoImmune Inc., a US-based clinical-stage biotech, and Formula Pharmaceutical Inc. agree...
January 16, 2020
Grifols presents its latest Alzheimer’s clinical trial data
December 6, 2019
Tetraphase Pharmaceuticals to Present Data at the 39th Annual Meeting of...
May 29, 2019
ReNeuron Announces Retinal Clinical Trial Progresses to Next Stage
March 18, 2019
Load more
HOT NEWS
Others
2019 BioSpace Life Sciences Ideal Employer Survey
Commercial
Sanofi Eyes Its Next CEO as Olivier Brandicourt Nears the End...
Others
Hexavalent DTaP-IPV-Hib-HepB Vaccine Safe and Effective in Premature Infants: Presented at...
Commercial
Amgen Sets Annual List Price for Osteoporosis Drug Evenity at $21,900
